ZOLOFT

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Italy, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug ZOLOFT contains one active pharmaceutical ingredient (API):

1 Sertraline UNII UTI8907Y6X - SERTRALINE HYDROCHLORIDE

Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake. Read about Sertraline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZOLOFT Film-coated tablet / Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB06	Sertraline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2236Q, 2237R, 8836C, 8837D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 552820020063517, 552820020063617, 552820020063717, 552820020063817, 552820020063917, 552820020064017
Country: CA	Health Products and Food Branch	Identifier(s): 01962779, 01962817, 02132702
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00253818, 00253830, 01041490, 01511062, 01883734, 01883740, 02711426, 02743136, 02743165, 02743975, 03497366, 03499425, 07544068, 07577837, 07577843
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 20.986-1-02-04, 4679-MEE-0419, 6107-MEE-0421
Country: EE	Ravimiamet	Identifier(s): 1008638, 1669181, 1669192, 1669204, 1669215, 1669226, 1669237, 1669248, 1669259, 1669260, 1669271, 1669282, 1669293, 1669305, 1669316, 1669327, 1831968
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 037697, 037879, 037994, 038091
Country: FR	Base de données publique des médicaments	Identifier(s): 60155788, 60683198
Country: HK	Department of Health Drug Office	Identifier(s): 36350
Country: IT	Agenzia del Farmaco	Identifier(s): 027753033, 027753045, 027753108, 027753110
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002230, 1019935, 1061976, 1061977, 1061978, 1061979, 1061980, 1061981, 1061982, 1061983, 1061984, 1061985, 1061986, 1061987, 1061988, 1061989, 1069176, 1086930, 1088370
Country: NG	Registered Drug Product Database	Identifier(s): 04-2796
Country: NL	Z-Index G-Standaard	Identifier(s): 14664992
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 39403, 59633
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5856, 5859
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100079719, 100079725
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67278001, W67278002, W67278003, W67278004, W67278005, W67278006, W67278007, W67278008, W67278009, W67278010, W67278011, W67278012, W67278013, W67278014, W67278015, W67278016, W67278017, W67279001, W67279002, W67279003, W67279004, W67279005, W67279006, W67279007, W67279008, W67279009, W67279010, W67279011, W67279012, W67279013, W67279014, W67279015, W67279016, W67279017, W67280001
Country: SG	Health Sciences Authority	Identifier(s): 07301P, 07302P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9243141, 9243142
Country: US	FDA, National Drug Code	Identifier(s): 0049-0050, 0049-4900, 0049-4910, 0049-4960, 55289-409, 70518-1913
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/1.2/0381